Fermenta Biotech Ltd: From Vitamin D3 Darling to Real Estate Landlord?

1. At a Glance

Fermenta Biotech (FBL) is that old-school pharma uncle who suddenly decided to moonlight as a property dealer. With ₹528 Cr FY25 sales, ₹105 Cr PAT, 26% OPM, and 25% ROE, the company looks healthier than the Vitamin D3 capsules it sells. Stock trades at P/E ~9 vs industry average ~33, making it look like a discount chemist shop. But scratch deeper, and you’ll see revenue split between bulk drugs (82%) and property monetization (18%)—basically a half-pharma, half-builder hybrid.

2. Introduction

Fermenta Biotech is not some 2020 IPO story; it dates back to 1951. First, it made APIs, then became a global Vitamin D3 supplier, and now it’s dabbling in Thane real estate like a retired Bollywood actor launching a food delivery app.

The company is famous for its non-China dependent Vitamin D3 supply chain, which became its big selling point post-COVID. It serves 350+ global clients in 60+ countries, including big pharma names who need Vitamin D3 for formulations, animal feed, and fortified food.

But here’s the twist: pharma is stable, yet growth is muted (5–10% CAGR). The real fireworks came when Fermenta started selling and leasing commercial property in Thane, raking in one-time chunky profits. Add to that a greenfield nutraceutical expansion in Sayakha, Gujarat, and the story starts to look like: “Pharma by day, Builder by night.”

Question for you: would you value it like Sun Pharma or like Oberoi Realty?

3. Business Model – WTF Do They Even Do?

• Pharma & APIs:
  • Global Vitamin D3 leader (59% of FY23 product revenue).
  • Other APIs for muscle relaxants, anti-flatulents (yes, medicines for fart control).
  • Enzymes for API manufacturing.
• Nutraceuticals & Biotech:
  • Vitamin K1, Vitamin E50, premixes for rice/oil fortification.
  • Fortified Rice Kernel (FRK) facility commissioned in Andhra Pradesh.
• Environmental Solutions: Enzymes for wastewater treatment.
• Real Estate Side Hustle:
  • Thane One IT park (2 lakh sq. ft.), leases and sales.
  • Sale deeds worth ₹13.6 Cr in FY24; ongoing development tie-ups with Mextech Developers.
  • Total land bank valuation ~₹500 Cr.

So yeah, Fermenta is pharma+nutraceuticals+biotech+real estate. Basically, a diversified buffet that confuses even the waiter.

4. Financials Overview

Commentary: Vitamin D3 is back in demand, margins are chunky, but profits fluctuate quarter-to-quarter like Sensex on budget day.

5. Valuation – Fair Value Range

• P/E